Raymond Sanchez
2020
In 2020, Raymond Sanchez earned a total compensation of $1.8M as Chief Medical Officer at Cerevel Therapeutics Holdings, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $275,280 |
|---|---|
| Option Awards | $1,000,000 |
| Salary | $465,000 |
| Other | $31,657 |
| Total | $1,771,937 |
Sanchez received $1M in option awards, accounting for 56% of the total pay in 2020.
Sanchez also received $275.3K in non-equity incentive plan, $465K in salary and $31.7K in other compensation.
Rankings
In 2020, Raymond Sanchez's compensation ranked 6,076th out of 13,090 executives tracked by ExecPay. In other words, Sanchez earned more than 53.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,076 out of 13,090 | 54th |
Division Manufacturing | 2,505 out of 5,621 | 55th |
Major group Chemicals And Allied Products | 1,005 out of 2,254 | 55th |
Industry group Drugs | 870 out of 1,954 | 56th |
Industry Pharmaceutical Preparations | 649 out of 1,459 | 56th |
Source: SEC filing on April 28, 2022.
Sanchez's colleagues
We found four more compensation records of executives who worked with Raymond Sanchez at Cerevel Therapeutics Holdings in 2020.